The government is releasing £3 million of new funding through Innovate UK to help accelerate integration of cell and gene therapies into health services after regulatory approval.
The funding will be used to drive capability development through a network of Advanced Therapies Treatment Centres to supply, maintain and deliver complex therapies in the NHS, and to develop apprenticeships in partnership with Medicines Manufacturing Industry Partnership.
“The government is releasing £3 million of new funding through Innovate UK to help accelerate integration of cell and gene therapies into health services “
“The investment by Innovate UK in these centres builds on its existing track record for innovation in medical science to tackle some of the most debilitating and devastating medical conditions affecting people today, including cancer, heart failure, ophthalmic disease and neurological conditions,” said Dr Ian Campbell, executive chair of Innovate UK. “We are excited to be driving forward our mission to integrate a new generation of medicines into mainstream healthcare and also building the UK’s position as a global hub in clinical development and commercialisation.”